In June 21, Gralon Healthcare reports that Innovative PHAR (00399.HK) announced that all the preconditions for the subscription of new convertible bonds and revision of existing convertible bonds agreements have been met. The subscription of new convertible bonds and the revision of existing convertible bonds have been completed on June 21, 2024.
领航医药生物科技(00399.HK)完成新可换股债券认购事项
Innovative Phar (00399.HK) has completed the subscription of new exchangeable bonds.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.